BioCentury
ARTICLE | Company News

Roche ending diagnostics deal with Pacific Biosciences

December 16, 2016 12:00 AM UTC

Pacific Biosciences of California Inc. (NASDAQ:PACB) dropped $3.01 (44%) to $3.89 on Thursday after it said Roche (SIX:ROG; OTCQX:RHHBY) plans to terminate a 2013 deal to develop and commercialize di...